Objective: a) To evaluate auxological changes under L-T4 therapy and post-therapy evolution of thyroid function in 69 children with mild and “idiopathic” subclinical hypothyroidism SH (Group A); b) to compare our results with those recorded in 92 SH untreated children (Group B). Design: Group A children were treated for 24 months and their TSH and FT4 levels 3 months after therapy withdrawal (27 months) were compared with those measured in untreated Group B at the end of a 24-month follow-up. Results: The prevalence of children who normalized TSH values at the end of follow-up was significantly higher in Group A, but the overall prevalence of the ones who either normalized or maintained unchanged TSH levels was very similar in the 2 groups, as well as that of children who exhibited a further TSH increase above 10 mU/l. In Group A TSH values at 27 months were positively associated with the baseline ones. In both groups no significant clinical and auxological changes were observed during follow-up. Conclusions: a) a two-year treatment with L-T4 in children with “idiopathic” and mild SH is not able to distinctly modify the natural course of SH, at least in terms of growth and post-therapy outcome of hyperthyrotropinemia; b) therapy is not able to prevent the risk of a further increase of TSH after treatment withdrawal; c) post-therapy outcome of TSH serum levels is significantly conditioned by baseline TSH.

Comparative evaluation of therapy with L-thyroxine versus no treatment in children with idiopathic and mild subclinical hypothyroidism

WASNIEWSKA, Malgorzata Gabriela;AVERSA, TOMMASO;VALENZISE, Mariella;LOMBARDO, Fortunato;DE LUCA, Filippo;
2012-01-01

Abstract

Objective: a) To evaluate auxological changes under L-T4 therapy and post-therapy evolution of thyroid function in 69 children with mild and “idiopathic” subclinical hypothyroidism SH (Group A); b) to compare our results with those recorded in 92 SH untreated children (Group B). Design: Group A children were treated for 24 months and their TSH and FT4 levels 3 months after therapy withdrawal (27 months) were compared with those measured in untreated Group B at the end of a 24-month follow-up. Results: The prevalence of children who normalized TSH values at the end of follow-up was significantly higher in Group A, but the overall prevalence of the ones who either normalized or maintained unchanged TSH levels was very similar in the 2 groups, as well as that of children who exhibited a further TSH increase above 10 mU/l. In Group A TSH values at 27 months were positively associated with the baseline ones. In both groups no significant clinical and auxological changes were observed during follow-up. Conclusions: a) a two-year treatment with L-T4 in children with “idiopathic” and mild SH is not able to distinctly modify the natural course of SH, at least in terms of growth and post-therapy outcome of hyperthyrotropinemia; b) therapy is not able to prevent the risk of a further increase of TSH after treatment withdrawal; c) post-therapy outcome of TSH serum levels is significantly conditioned by baseline TSH.
2012
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/2438226
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact